Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The influence on survival of glucocorticoid induced diabetes in cancer patients with metastatic spinal cord compression

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Cerebral infarction after fractionated stereotactic radiation therapy of benign anterior skull base tumors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Survival and failure types after radiation therapy of vulvar cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Coronary plaque composition assessed by cardiac computed tomography using adaptive Hounsfield unit thresholds

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Mismatch 'never events' in hip and knee arthroplasty: a cohort and intervention study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background and purpose: The influence of glucocorticoid induced hyperglycemia on survival in patients with metastatic spinal cord compression (MSCC) is unknown.

Materials and methods: In a prospective, observational cohort study 131 patients with MSCC referred to radiotherapy, 30 Gray (Gy) in 10 fractions, and treated with ≥100 mg prednisolone a day were followed with daily blood glucose measurements during radiotherapy.

Results: During follow-up a total of 56 patients 43% (95% CI = 35-52%) presented plasma glucose values diagnostic of diabetes. Sixteen patients who developed diabetes were treated with insulin, 12% (95% CI = [6%; 18%]) of the total population. The patients developing diabetes with need for insulin therapy during glucocorticoid therapy had a significantly increased mortality compared to those with normal glucose metabolism and with diabetes without need for therapy, hazard ratio = 2.1 (95% CI = 1.08-4.09, p = 0.0285).

Discussion: To our knowledge this is the first prospective study to describe the influence of glucocorticoid induced diabetes on survival in patients with MSCC from different primary tumors.

Conclusions: The results indicate that development of diabetes during high-dose glucocorticoid therapy needing insulin treatment in patients with MSCC from different primary tumors is associated with reduced survival.

OriginalsprogEngelsk
TidsskriftClinical and Translational Radiation Oncologi
Vol/bind11
Sider (fra-til)19-25
Antal sider7
ISSN2405-6308
DOI
StatusUdgivet - 2018

ID: 54881976